Page last updated: 2024-10-27

glimepiride and Death, Sudden, Cardiac

glimepiride has been researched along with Death, Sudden, Cardiac in 2 studies

glimepiride: structure given in first source

Death, Sudden, Cardiac: Unexpected rapid natural death due to cardiovascular collapse within one hour of initial symptoms. It is usually caused by the worsening of existing heart diseases. The sudden onset of symptoms, such as CHEST PAIN and CARDIAC ARRHYTHMIAS, particularly VENTRICULAR TACHYCARDIA, can lead to the loss of consciousness and cardiac arrest followed by biological death. (from Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 7th ed., 2005)

Research Excerpts

ExcerptRelevanceReference

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Dhopeshwarkar, N1
Brensinger, CM2
Bilker, WB2
Soprano, SE1
Flory, JH2
Dawwas, GK1
Gagne, JJ2
Hennessy, S2
Leonard, CE2
Aquilante, CL1
Boudreau, DM1
Deo, R1
Mangaali, MJ1

Other Studies

2 other studies available for glimepiride and Death, Sudden, Cardiac

ArticleYear
Risk of sudden cardiac arrest and ventricular arrhythmia with sulfonylureas: An experience with conceptual replication in two independent populations.
    Scientific reports, 2020, 06-22, Volume: 10, Issue:1

    Topics: Aged; Cohort Studies; Death, Sudden, Cardiac; Diabetes Mellitus, Type 2; Female; Glipizide; Glyburid

2020
Comparative Safety of Sulfonylureas and the Risk of Sudden Cardiac Arrest and Ventricular Arrhythmia.
    Diabetes care, 2018, Volume: 41, Issue:4

    Topics: Aged; Arrhythmias, Cardiac; Cause of Death; Death, Sudden, Cardiac; Diabetic Angiopathies; Female; G

2018